未登录

J

James E. Pease

imperial college london

H指数:49

被引数:6,311

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evidence for a Two-Step Model for Activation of GPR25 by the Chemoattractant CXCL17

证据表明化学趋化因子CXCL17以两步模型激活GPR25

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

IF3.3

2026-05-280

OAAI

The N-terminal ELR plus motif of the neutrophil attractant CXCL8 confers susceptibility to degradation by the Group A streptococcal protease, SpyCEP

中性粒细胞趋化因子CXCL8的N端ELR plus基序使其易受A族链球菌蛋白酶SpyCEP的降解。

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2025-05-010

OAAI

Reduced SOX17 in HPAECs drives CXCL10/11 upregulation and CXCR3-dependant lymphocyte migration in vitro

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Atypical chemoattractants and their receptors: A potential gateway to novel therapeutic strategies

IF3.7

2024-06-010

PRE

Structure-activity studies of Streptococcus pyogenes enzyme SpyCEP reveal high affinity for CXCL8 in the SpyCEP C-terminal

SCIENTIFIC REPORTS

IF3.9

2023-11-030

OAAI

CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-10-243

OAAI

What defines a chemokine?-The curious case of CXCL17

IF3.7

2023-08-016

OAAI

Matrix Metalloproteinase-12 Supports Pulmonary B Cell Follicle Formation and Local Antibody Responses During Asthma

基质Metalloproteinase-12支持哮喘期间肺b细胞滤泡形成和局部抗体反应

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

IF19.4

2022-12-012

OAAI

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy

STING激动剂在肿瘤免疫治疗临床开发中的挑战与机遇

JOURNAL OF CLINICAL MEDICINE

IF2.9

2020-10-16165

OAAI

A degradatory fate for CCR4 suggests a primary role in Th2 inflammation

JOURNAL OF LEUKOCYTE BIOLOGY

IF3.1

2020-02-1315

OAAI

Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans

SCIENCE IMMUNOLOGY

IF16.3

2019-06-0797

OAAI

A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP

JOURNAL OF IMMUNOLOGY

IF3.4

2019-06-0113

OAAI

Tipping the balance: A biased nanobody antagonist of CCR3 with potential for the treatment of eosinophilic inflammation

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2019-02-0110

PREAI

Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35

JOURNAL OF IMMUNOLOGY

IF3.4

2018-07-1533

OAAI

CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration

SCIENTIFIC REPORTS

IF3.9

2018-06-2171

OAAI

Eosinophils on trial

CLINICAL AND EXPERIMENTAL ALLERGY

IF5.2

2018-04-270

OAAI

Designing small molecule CXCR3 antagonists

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2016-12-3018

PREAI

Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery?

JOURNAL OF LEUKOCYTE BIOLOGY

IF3.1

2015-12-2325

OA

Bisphenol A suppresses Th1-type immune response in human peripheral blood mononuclear cells in vitro

IMMUNOLOGY LETTERS

IF2.8

2015-12-0128

OAAI

Pulmonary Epithelial Cell-Derived Cytokine TGF-β1 Is a Critical Cofactor for Enhanced Innate Lymphoid Cell Function

IF26.3

2015-11-01137

OAAI